Topic - Presenter
Morning session
Welcome
Karl Mahler, Head of Investor Relations
Pharma strategy, Portfolio planning, Productivity and new technologies
Bill Anderson, CEO Roche Pharmaceuticals
Market opportunities; Pricing & Access
Teresa Graham, Head Global Product Strategy
Oncology franchise
Sandra Horning, Chief Medical Officer and Head Global Product Development
Neuroscience franchise
Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
Afternoon sessions (breakouts)
Immunology & Infectious diseases
Cristin Hubbard, Senior Vice President, Global Product Strategy, Immunology, Infections Diseases and Ophthalmology
Zafar Hakim, Senior Director, Disease Area Strategy Immunology, Infectious Diseases & Ophthalmology, Global Product Strategy
Late stage pipeline Ophthalmology
Atul Dandekar Ophthalmology Franchise Head in Global Product Strategy
Sascha Fauser, Head of Ophthalmology group (Discovery and Translational Medicine)
Digitalisation & Personalized healthcare
Bryn Roberts Global Head of Operations & Informatics for Pharma Research and Early Development
Appendix
Pipeline overview
Patient populations